Aligos Therapeutics Liver Disease Updates Coming at Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...
Delcath Systems (Nasdaq: DCTH), a company specializing in interventional oncology with a...
Biotechnology companies eGenesis and United Therapeutics Corporation have reported that the FDA greenlit their clinical trials of genetically modified pig...
Delcath Systems (Nasdaq: DCTH), an interventional oncology company specializing in liver cancer treatments, has announced...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
The initiative aims to promote awareness, screening and early detection for chronic kidney disease to eliminate barriers and disparities facing...